Influence of COVID‐19 in patients with concurrent tuberculosis coinfections

Wang, Guoying; Cai, Linghao; Chen, Dandan; Teng, Tieshan; Xie, Longxiang

doi:10.1002/jmv.26801

Cited by 2 publications

(1 citation statement)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…According to Coronel et al, tuberculosis patients have a very high risk of severe illness and mortality from COVID-19 [3]. Furthermore, incorrect treatment and hazardous conduct also increase the possibility of developing new diseases [4,5]. Therefore, this study aims to determine the epidemiology of the number of cases of pulmonary tuberculosis and COVID-19 in Indonesia, specifically in the province of East Java.…”

Section: Introductionmentioning

confidence: 99%

Comparison Epidemiology between Tuberculosis and COVID-19 in East Java Province, Indonesia: An Analysis of Regional Surveillance Data in 2020

et al. 2022

View full text Add to dashboard Cite

Tuberculosis and COVID-19 are among the infectious diseases that constitute a public health concern. Therefore, this study aims to examine the recent epidemiology of tuberculosis and COVID-19 in East Java Province, Indonesia, in 2020. Case-based surveillance data were acquired with a retrospective design between January and December 2020 by the East Java Health Officer. The data were analyzed using Quantum Geographic Information System (QGIS) for mapping, and Microsoft Excel for recording. Furthermore, the statistical analysis (Spearman correlation test) was carried out via Statistical Package for Social Science (SPSS) applications. A total number of 38,089 confirmed cases of tuberculosis was recorded, with an incidence rate of 95.49/100,000 population, a case fatality rate (CFR) of 3.6%, and an average treatment success rate of 87.78%. COVID-19 is a new viral disease, with a total of 84,133 confirmed COVID-19 cases in East Java, with an incidence rate of 232.9/100,000 population. The highest incidence rate was found in Mojokerto city, while the lowest was found in Sampang. Furthermore, the CFR values of tuberculosis and COVID-19 were 1.4% and 6.8%, respectively. The regional survey in East Java Province showed that the incidence of tuberculosis remains high. This indicated that the search for active cases and preventive promotion was not completed. Therefore, inter-sectoral collaboration can be adapted to provide suitable tuberculosis health care.

show abstract

Section: Introductionmentioning

confidence: 99%

Comparison Epidemiology between Tuberculosis and COVID-19 in East Java Province, Indonesia: An Analysis of Regional Surveillance Data in 2020

et al. 2022

View full text Add to dashboard Cite

show abstract

Cohort study of the mortality among patients in New York City with tuberculosis and COVID-19, March 2020 to June 2022

Easton

Salerno

Trieu

et al. 2023

PLOS Glob Public Health

View full text Add to dashboard Cite

Both tuberculosis (TB) and COVID-19 can affect the respiratory system, and early findings suggest co-occurrence of these infectious diseases can result in elevated mortality. A retrospective cohort of patients who were diagnosed with TB and COVID-19 concurrently (within 120 days) between March 2020 and June 2022 in New York City (NYC) was identified. This cohort was compared with a cohort of patients diagnosed with TB-alone during the same period in terms of demographic information, clinical characteristics, and mortality. Cox proportional hazards regression was used to compare mortality between patient cohorts. One hundred and six patients with concurrent TB/COVID-19 were identified and compared with 902 patients with TB-alone. These two cohorts of patients were largely demographically and clinically similar. However, mortality was higher among patients with concurrent TB/COVID-19 in comparison to patients with TB-alone, even after controlling for age and sex (hazard ratio 2.62, 95% Confidence Interval 1.66–4.13). Nearly one in three (22/70, 31%) patients with concurrent TB/COVID-19 aged 45 and above died during the study period. These results suggest that TB patients with concurrent COVID-19 were at high risk for mortality. It is important that, as a high-risk group, patients with TB are prioritized for resources to quickly diagnose and treat COVID-19, and provided with tools and information to protect themselves from COVID-19.

show abstract

Influence of COVID‐19 in patients with concurrent tuberculosis coinfections

Abstract: analyzed the data. Tieshan Teng, Qiming Li, and Longxiang Xie drafted the manuscript.

Cited by 2 publications

References 9 publications

Comparison Epidemiology between Tuberculosis and COVID-19 in East Java Province, Indonesia: An Analysis of Regional Surveillance Data in 2020

Comparison Epidemiology between Tuberculosis and COVID-19 in East Java Province, Indonesia: An Analysis of Regional Surveillance Data in 2020

Cohort study of the mortality among patients in New York City with tuberculosis and COVID-19, March 2020 to June 2022

Contact Info

Product

Resources

About